Search Results

There are 27094 results for: content related to: Lamivudine treatment for fulminant hepatic failure due to acute exacerbation of chronic hepatitis B infection

  1. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  2. Lamivudine salts with improved solubilities

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 6, June 2012, Pages: 2143–2154, Felipe T. Martins, Rudy Bonfilio, Magali B. De Araújo and Javier Ellena

    Version of Record online : 14 MAR 2012, DOI: 10.1002/jps.23117

  3. Management of viral hepatitis B

    Journal of Gastroenterology and Hepatology

    Volume 17, Issue s1, February 2002, Pages: S125–S145, CHUTIMA PRAMOOLSINSUP

    Version of Record online : 8 MAY 2002, DOI: 10.1046/j.1440-1746.17.s1.3.x

  4. Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation

    Intervention Review

    The Cochrane Library

    Lior H Katz, Ran Tur-Kaspa, Daniel G Guy and Mical Paul

    Published Online : 7 JUL 2010, DOI: 10.1002/14651858.CD006005.pub2

  5. You have free access to this content
    Chronic hepatitis B

    Hepatology

    Volume 45, Issue 2, February 2007, Pages: 507–539, Anna S. F. Lok and Brian J. McMahon

    Version of Record online : 26 JAN 2007, DOI: 10.1002/hep.21513

  6. Efficacy of lamivudine re-treatment for relapsed patients after an initial lamivudine therapy in HBeAg-positive chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 12, Issue 4, July 2005, Pages: 393–397, J. W. Shin, N. H. Park, J. H. Park, J. H. Park, I. D. Jeong, S-J. Bang, K. R. Joo and D. H. Kim

    Version of Record online : 14 MAR 2005, DOI: 10.1111/j.1365-2893.2005.00606.x

  7. Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine

    Liver International

    Volume 31, Issue 5, May 2011, Pages: 667–675, Rifaat Safadi, Qing Xie, Yagang Chen, You-Kuan Yin, Lai Wei, Seong Gyu Hwang, Eli Zuckerman, Ji-Dong Jia and Patricia Lopez

    Version of Record online : 29 OCT 2010, DOI: 10.1111/j.1478-3231.2010.02360.x

  8. Should lamivudine monotherapy be stopped or continued in patients infected with hepatitis B with favorable responses after more than 5 years of treatment?

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 34–42, Jung Hyun Kwon, Jeong Won Jang, Jong Young Choi, Chung-Hwa Park, Sun Hong Yoo, Si Hyun Bae and Seung Kew Yoon

    Version of Record online : 14 NOV 2012, DOI: 10.1002/jmv.23421

  9. Efficacy of switching to entecavir monotherapy in Japanese lamivudine-pretreated patients

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 5, May 2010, Pages: 892–898, Fumitaka Suzuki, Norio Akuta, Yoshiyuki Suzuki, Hiromi Yatsuji, Hitomi Sezaki, Yasuji Arase, Miharu Hirakawa, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Kenji Ikeda, Mariko Kobayashi, Sachiyo Watahiki and Hiromitsu Kumada

    Version of Record online : 30 OCT 2009, DOI: 10.1111/j.1440-1746.2009.06161.x

  10. Management of chronic hepatitis B virus infection: a new era of disease control

    Internal Medicine Journal

    Volume 36, Issue 2, February 2006, Pages: 100–113, G. C. Farrell and N. C. Teoh

    Version of Record online : 10 FEB 2006, DOI: 10.1111/j.1445-5994.2006.01027.x

  11. You have free access to this content
    Prophylaxis against de novo hepatitis B for liver transplantation utilizing hep B core (+) donors: does hepatitis B immunoglobulin provide a survival advantage?

    Transplant International

    Volume 24, Issue 6, June 2011, Pages: 570–581, Guy N. Brock, Farida Mostajabi, Nicole Ferguson, Christopher J. Carrubba, Mary Eng, Joseph F. Buell and Michael R. Marvin

    Version of Record online : 15 MAR 2011, DOI: 10.1111/j.1432-2277.2011.01236.x

  12. Pharmacological interventions for acute hepatitis B infection

    Intervention Review

    The Cochrane Library

    Konstantinos Mantzoukis, Manuel Rodríguez-Perálvarez, Elena Buzzetti, Douglas Thorburn, Brian R Davidson, Emmanuel Tsochatzis and Kurinchi Selvan Gurusamy

    Published Online : 21 MAR 2017, DOI: 10.1002/14651858.CD011645.pub2

  13. You have free access to this content
    Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?

    Liver International

    Volume 32, Issue 4, April 2012, Pages: 544–553, Hans L. Tillmann, Kalliopi Zachou and George N. Dalekos

    Version of Record online : 15 NOV 2011, DOI: 10.1111/j.1478-3231.2011.02682.x

  14. You have free access to this content
    Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: Antiviral and immunological activity

    Hepatology

    Volume 42, Issue 5, November 2005, Pages: 1028–1036, Eirini I. Rigopoulou, Deepak Suri, Shilpa Chokshi, Ivana Mullerova, Steven Rice, Richard S. Tedder, Roger Williams and Nikolai V. Naoumov

    Version of Record online : 25 OCT 2005, DOI: 10.1002/hep.20888

  15. Hepatitis B virus polymerase variants associated with entecavir drug resistance in treatment-naive patients

    Journal of Viral Hepatitis

    Volume 14, Issue 12, December 2007, Pages: 835–840, R. Jardi, F. Rodriguez-Frias, M. Schaper, G. Ruiz, I. Elefsiniotis, R. Esteban and M. Buti

    Version of Record online : 24 SEP 2007, DOI: 10.1111/j.1365-2893.2007.00877.x

  16. You have free access to this content
    A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial

    Hepatology

    Volume 47, Issue 3, March 2008, Pages: 844–853, Chiun Hsu, Chao A. Hsiung, Ih-Jen Su, Wei-Shou Hwang, Ming-Chung Wang, Sheng-Fung Lin, Tseng-Hsi Lin, Hui-Hua Hsiao, Ji-Hsiung Young, Ming-Chih Chang, Yu-Min Liao, Chi-Cheng Li, Hung-Bo Wu, Hwei-Fang Tien, Tsu-Yi Chao, Tsang-Wu Liu, Ann-Lii Cheng and Pei-Jer Chen

    Version of Record online : 27 DEC 2007, DOI: 10.1002/hep.22106

  17. Developmental Pharmacokinetic Changes of Lamivudine in Infants and Children

    The Journal of Clinical Pharmacology

    Volume 52, Issue 12, December 2012, Pages: 1824–1832, Dr Adriana H. Tremoulet, Dr Mina Nikanjam, Dr Tim R. Cressey, Dr Kulkanya Chokephaibulkit, Dr Ross McKinney, Dr Mark Mirochnick and Dr Edmund V. Capparelli

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011426563

  18. Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults.

    Intervention Review

    The Cochrane Library

    Nandi Siegfried, Pieta JU van Deventer, Fazleh Ahmed Mahomed and George W Rutherford

    Published Online : 19 APR 2006, DOI: 10.1002/14651858.CD004535.pub2

  19. Lamivudine prophylaxis is effective in reducing hepatitis B reactivation and reactivation-related mortality in chemotherapy patients: a meta-analysis

    Liver International

    Volume 28, Issue 1, January 2008, Pages: 28–38, Lenna A. Martyak, Ehsan Taqavi and Sammy Saab

    Version of Record online : 1 NOV 2007, DOI: 10.1111/j.1478-3231.2007.01618.x

  20. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study

    Journal of Viral Hepatitis

    Volume 16, Issue 2, February 2009, Pages: 94–103, W.-M. Xu, Y.-T. Cui, L. Wang, H. Yang, Z.-Q. Liang, X.-M. Li, S.-L. Zhang, F.-Y. Qiao, F. Campbell, C.-N. Chang, S. Gardner and M. Atkins

    Version of Record online : 8 OCT 2008, DOI: 10.1111/j.1365-2893.2008.01056.x